@WHO: RT @WHOUganda: .@WHOUganda today handed over to @MinofHealthUG at @nmsuganda 4,160 additional doses of 2 candidate vaccines against the #Ebola Sudan strain. Produced by Oxford & Merck pharmaceutical companies, they will be used in a clinical trial led by the @Lung_Institute #Uganda. https://t.co/mDxlR0AgqJ

http://twitter.com/WHO
via IFTTT